Myeloma bone disease: Pathophysiology and management.
Rebecca Silbermann1, G David Roodman1
1Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
Journal of Bone Oncology
|February 25, 2016
Summary
Multiple myeloma bone disease causes severe bone loss by disrupting bone formation and resorption. New therapies aim to restore bone health by targeting both osteoclast and osteoblast regulation.
Area of Science:
- Oncology
- Bone Biology
- Cancer Therapeutics
Background:
- Multiple myeloma bone disease (MMBD) is characterized by impaired bone formation and resorption.
- Myeloma bone lesions are osteolytic, leading to pain, fractures, hypercalcemia, and increased mortality.
- The bone marrow microenvironment critically influences abnormal bone remodeling in MMBD.
Purpose of the Study:
- To review the mechanisms underlying MMBD.
- To discuss current and emerging therapeutic strategies for MMBD management.
Main Methods:
- Literature review of mechanisms driving MMBD.
- Analysis of therapeutic approaches targeting bone remodeling in MMBD.
Main Results:
- Myeloma cells promote osteoclast (OCL) formation and suppress osteoblast (OBL) formation.
- Interactions within the bone marrow microenvironment drive bone destruction and tumor growth.
- Current therapies focus on OCL inhibition, with anabolic agents under investigation.
Conclusions:
- Understanding MMBD mechanisms is crucial for developing effective treatments.
- Targeting both OCL and OBL pathways offers potential for improved MMBD management.
- Future therapies may include agents with anabolic effects to restore bone health.
More Related Videos
Related Concept Videos
01:29Bone Disorders
7.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.0K
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:22Bone Marrow Sampling and Transplants
2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
917
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
917
02:07Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
01:27Disorders of Leukocytes
2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K